Recurrent intracerebral hemorrhage: new problem with an old target?
Dr. Sheth describes novel approaches for the prevention of recurrent intracerebral hemorrhage in brain hemorrhage survivors.
Caceres JA et al. Emerg Med Clin North Am. 2012;30:771-794. Woo D et al. Stroke. 2013;44:e120-125. Karsy M et al. Neurosurg Focus. 2017;42:E3. Joon An S et al. J Stroke. 2017;19:3-10. Poon MTC et al. J Neurol Neurosurg Psychiatry. 2014;85:660-667.
Dr. Sheth has received personal compensation for royalty, license fees, or contractual rights payments from
Alva Health. His institution (Yale) has received research support from Biogen, Novartis, Bard, Hyperfine.